Category: Medical
Living with Crohn’s and Diabetes: Breaking Down Treatment Barriers
New research reveals that people with both Crohn’s disease and diabetes are less likely to receive advanced IBD treatments, often leading to more severe symptoms and surgeries. Understanding this treatment gap can help patients advocate for better, more comprehensive care.
New IBD Companion App Offers Real Support for Daily Challenges
Takeda’s new “For You, With You IBD” app offers comprehensive support for daily IBD challenges, including bathroom location, medication reminders, and symptom tracking. Developed with patient input, this tool represents a shift toward technology that truly understands the complexities of living with Crohn’s and colitis.
Why Your Voice Matters Most in IBD Treatment Decisions
New research shows that when IBD patients are truly involved in treatment switching decisions, outcomes improve significantly. Being heard isn’t just nice to have—it’s essential for successful care.
Precision Microbiota Therapy: A New Hope for Crohn’s Disease
New research into precision microbiota therapy could revolutionize Crohn’s disease treatment by tailoring interventions to each person’s unique gut bacteria profile. This personalized approach aims to restore microbial balance rather than just manage symptoms, offering hope for more effective and individualized IBD care.
Breakthrough IBD Therapies Bringing Real Hope in 2025
Revolutionary AI-driven precision medicine and breakthrough therapies for complex IBD complications are transforming treatment from symptom management to truly personalized care. These emerging advances offer unprecedented hope for better outcomes and improved quality of life for the entire IBD community.
Silent Liver Warnings: What IBD Patients Need to Know
For IBD patients taking medications that affect liver function, recognizing the subtle early warning signs of liver disease becomes crucial. Learn how to distinguish between typical IBD symptoms and potential liver concerns, and discover why our community’s existing monitoring systems provide a unique advantage in early detection.
PSC and IBD in Kids: When Two Conditions Create New Challenges
New research reveals that children with both IBD and primary sclerosing cholangitis face significantly increased health risks, including 28-fold higher cancer risk. This highlights the critical importance of comprehensive monitoring and specialized care for complex pediatric IBD cases.
New Hope for Kids With UC: Promising Treatment Shows Real Results
New research on mirikizumab shows promising results for children with ulcerative colitis, with meaningful symptom improvement in just 12 weeks and minimal side effects. This targeted treatment represents hope for families seeking safer, more effective options for pediatric UC.
How One Surgeon Changed Colorectal Care Forever
Dr. Steven D. Wexner’s groundbreaking work in colorectal surgery has transformed treatment options for IBD patients, particularly through innovations like the J-pouch procedure. His legacy of combining technical excellence with compassionate care continues to benefit patients worldwide through improved surgical techniques and enhanced quality of life outcomes.
Could Natural Compounds Hold the Key to IBD Healing?
New research on isobutyrate reveals how naturally occurring food compounds might restore gut balance and reduce IBD inflammation. This represents a promising shift toward working with our body’s healing mechanisms rather than just suppressing symptoms.
